GSK1265744 demonstrates robust in vitro activity against various clades of HIV-1
- PMID: 25469523
- PMCID: PMC4439214
- DOI: 10.1097/QAI.0000000000000469
GSK1265744 demonstrates robust in vitro activity against various clades of HIV-1
References
-
- Roehr B. FDA approves first drug to prevent HIV infection. Bmj. 2012;345:e4879. - PubMed
-
- Plosker GL. Emtricitabine/tenofovir disoproxil fumarate: a review of its use in HIV-1 pre-exposure prophylaxis. Drugs. 2013 Mar;73(3):279–291. - PubMed
-
- Marrazzo J, Ramjee G, Nair G. Presented at: 20th Conference on Retroviruses and Opportunistic Infections. Atlanta, GA: 2013. Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir/emtricitabine or vaginal tenofovir gel in the VOICE study (MTN 003)
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical